CardioGenics (OTCMKTS:CGNH) Stock Price Crosses Above Two Hundred Day Moving Average – Should You Sell?

CardioGenics Holdings Inc. (OTCMKTS:CGNH – Get Free Report)’s stock price crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $0.00 and traded as high as $0.0001. CardioGenics shares last traded at $0.00, with a volume of 0 shares changing hands.

CardioGenics Trading Down 100.0%

Get CardioGenics alerts:

About CardioGenics

(Get Free Report)

CardioGenics Holdings, Inc (OTCMKTS: CGNH) is a clinical diagnostics company specializing in the development, production and commercialization of immunoenzymatic assay kits and instruments for the detection and monitoring of cardiovascular disease. The company’s core focus lies in high-sensitivity cardiac biomarkers, which support early diagnosis of myocardial infarction, heart failure and related conditions. CardioGenics leverages proprietary antibody technology and assay platforms to deliver quantitative test results in clinical laboratory settings.

Headquartered in the United States, CardioGenics serves healthcare providers and diagnostic laboratories globally through a combination of direct sales channels and distribution partners.

See Also

• Five stocks we like better than CardioGenics
• Striking Oil: How the U.S. Play for Venezuela Fuels Supermajors
• J.M. Smucker Stock’s Rally Has More Than Tariffs Behind It
• Wendy’s Rally Fades After Trian Steps Back: Was It Ever Real?
• GitLab’s Earnings Beat Just Gave Software Bulls a New SaaSpocalypse Test

Receive News & Ratings for CardioGenics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CardioGenics and related companies with MarketBeat.com's FREE daily email newsletter.